Jeffrey Cohen, DPM
Foot & Ankle Surgery · Round Rock, TXNPI 1811950249
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,330 of the $10,103 with a category attached, or 62.7%. 49 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 40.2% of the total. Reporting peaked in 2021 at $2,043 and has fallen 52.9% since, to $963 in 2025.
Across 231 payments — averaging $43.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$4K
- Medinc Of Texas$981
- Stryker$652
- AbbVie$490
- Kerecis Limited$322
- Smith+Nephew$314
- plus $3K from 43 others
What the payments were for
- Travel & lodging$2,89829%
- Food & beverage$6,33063%
- Education$8619%
- Entertainment$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$3,296
- SONICANCHOR$167
- AUGMENT INJECTABLE$156
- Grafix$148
- Flexitouch Plus$132
- ENTRE$132
- Evoke$124
How this compares
$10,103 in reported general payments places this provider in the 70th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 86 | $1,351 |
| Colchicine | 21 | $737 |
| Allopurinol | 35 | $643 |
| Terbinafine Hcl | 31 | $590 |
| CiclopiroxCiclopirox Olamine | 17 | $447 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 46 | $195 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $83 |
| Meloxicam | 23 | $38 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Round Rock
- Jonathan SmedleyRound Rock$105K
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
- Mark DaltonAustin$1.9M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$928K
- Sherman NaglerHouston$602K
- John EarlyDallas$553K
- Michael DowneySouthlake$475K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.